Escherichia albertii

Last updated

Escherichia albertii
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Pseudomonadota
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Escherichia
Species:
E. albertii
Binomial name
Escherichia albertii
(Huys et al. 2003)

Escherichia albertii is a Gram-negative species of bacteria within the same genus as E. coli . It was recognised to cause disease after being isolated from the stools of children with diarrhea in Bangladesh [1] [2] , and was originally thought to be Hafnia alvei based on biochemical assays [1] . The bacterium was reclassified in 2003 as a novel species based on its genetic features [3] [4] , and was named E. albertii in honour of the microbiologist who first described the species [5] . E. albertii differs from typical E. coli in being nonmotile and unable to ferment lactose.

As a human gastrointestinal pathogen, E. albertii is often linked to food- or water-borne outbreaks of disease [6] [7] , and can cause sporadic cases of bacteraemia [8] . The species may be misidentified as Enteropathogenic E. coli due to its production of intimin [9] [10] . It is also responsible for disease or subclinical infection in domestic and wild birds, where it may be a reservoir for human disease [6] [11] [12] [13] .

Related Research Articles

<i>Escherichia coli</i> Enteric, rod-shaped, gram-negative bacterium

Escherichia coli ( ESH-ə-RIK-ee-ə KOH-ly) is a gram-negative, facultative anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is commonly found in the lower intestine of warm-blooded organisms. Most E. coli strains are harmless, but some serotypes such as EPEC, and ETEC are pathogenic and can cause serious food poisoning in their hosts, and are occasionally responsible for food contamination incidents that prompt product recalls. Most strains are part of the normal microbiota of the gut and are harmless or even beneficial to humans (although these strains tend to be less studied than the pathogenic ones). For example, some strains of E. coli benefit their hosts by producing vitamin K2 or by preventing the colonization of the intestine by pathogenic bacteria. These mutually beneficial relationships between E. coli and humans are a type of mutualistic biological relationship — where both the humans and the E. coli are benefitting each other. E. coli is expelled into the environment within fecal matter. The bacterium grows massively in fresh fecal matter under aerobic conditions for three days, but its numbers decline slowly afterwards.

<i>Escherichia coli</i> O157:H7 Serotype of the bacteria Escherichia coli

Escherichia coli O157:H7 is a serotype of the bacterial species Escherichia coli and is one of the Shiga-like toxin–producing types of E. coli. It is a cause of disease, typically foodborne illness, through consumption of contaminated and raw food, including raw milk and undercooked ground beef. Infection with this type of pathogenic bacteria may lead to hemorrhagic diarrhea, and to kidney failure; these have been reported to cause the deaths of children younger than five years of age, of elderly patients, and of patients whose immune systems are otherwise compromised.

<i>Shigella</i> Genus of bacteria

Shigella is a genus of bacteria that is Gram-negative, facultatively anaerobic, non–spore-forming, nonmotile, rod-shaped, and is genetically closely related to Escherichia. The genus is named after Kiyoshi Shiga, who discovered it in 1897.

<span class="mw-page-title-main">Shiga toxin</span> Family of related toxins

Shiga toxins are a family of related toxins with two major groups, Stx1 and Stx2, expressed by genes considered to be part of the genome of lambdoid prophages. The toxins are named after Kiyoshi Shiga, who first described the bacterial origin of dysentery caused by Shigella dysenteriae. Shiga-like toxin (SLT) is a historical term for similar or identical toxins produced by Escherichia coli. The most common sources for Shiga toxin are the bacteria S. dysenteriae and some serotypes of Escherichia coli (STEC), which includes serotypes O157:H7, and O104:H4.

<span class="mw-page-title-main">Coliform bacteria</span> Group of bacterial species

Coliform bacteria are defined as either motile or non-motile Gram-negative non-spore forming bacilli that possess β-galactosidase to produce acids and gases under their optimal growth temperature of 35–37 °C. They can be aerobes or facultative aerobes, and are a commonly used indicator of low sanitary quality of foods, milk, and water. Coliforms can be found in the aquatic environment, in soil and on vegetation; they are universally present in large numbers in the feces of warm-blooded animals as they are known to inhabit the gastrointestinal system. While coliform bacteria are not normally causes of serious illness, they are easy to culture, and their presence is used to infer that other pathogenic organisms of fecal origin may be present in a sample, or that said sample is not safe to consume. Such pathogens include disease-causing bacteria, viruses, or protozoa and many multicellular parasites. Every drinking water source must be tested for the presence of these total coliform bacteria.

<i>Escherichia</i> Genus of bacteria

Escherichia is a genus of Gram-negative, non-spore-forming, facultatively anaerobic, rod-shaped bacteria from the family Enterobacteriaceae. In those species which are inhabitants of the gastrointestinal tracts of warm-blooded animals, Escherichia species provide a portion of the microbially derived vitamin K for their host. A number of the species of Escherichia are pathogenic. The genus is named after Theodor Escherich, the discoverer of Escherichia coli. Escherichia are facultative aerobes, with both aerobic and anaerobic growth, and an optimum temperature of 37 °C. Escherichia are usually motile by flagella, produce gas from fermentable carbohydrates, and do not decarboxylate lysine or hydrolyze arginine. Species include E. albertii, E. fergusonii, E. hermannii, E. ruysiae, E. marmotae and most notably, the model organism and clinically relevant E. coli. Formerly, Shimwellia blattae and Pseudescherichia vulneris were also classified in this genus.

<i>Shigella flexneri</i> Species of bacterium

Shigella flexneri is a species of Gram-negative bacteria in the genus Shigella that can cause diarrhea in humans. Several different serogroups of Shigella are described; S. flexneri belongs to group B. S. flexneri infections can usually be treated with antibiotics, although some strains have become resistant. Less severe cases are not usually treated because they become more resistant in the future. Shigella are closely related to Escherichia coli, but can be differentiated from E.coli based on pathogenicity, physiology and serology.

<span class="mw-page-title-main">Subclinical infection</span> Nearly or completely asymptomatic infection

A subclinical infection—sometimes called a preinfection or inapparent infection—is an infection by a pathogen that causes few or no signs or symptoms of infection in the host. Subclinical infections can occur in both humans and animals. Depending on the pathogen, which can be a virus or intestinal parasite, the host may be infectious and able to transmit the pathogen without ever developing symptoms; such a host is called an asymptomatic carrier. Many pathogens, including HIV, typhoid fever, and coronaviruses such as COVID-19 spread in their host populations through subclinical infection.

<span class="mw-page-title-main">Intimin</span>

Intimin is a virulence factor (adhesin) of EPEC and EHEC E. coli strains. It is an attaching and effacing (A/E) protein, which with other virulence factors is necessary and responsible for enteropathogenic and enterohaemorrhagic diarrhoea.

The discovery of disease-causing pathogens is an important activity in the field of medical science. Many viruses, bacteria, protozoa, fungi, helminthes and prions are identified as a confirmed or potential pathogen. In the United States, a Centers for Disease Control program, begun in 1995, identified over a hundred patients with life-threatening illnesses that were considered to be of an infectious cause, but that could not be linked to a known pathogen. The association of pathogens with disease can be a complex and controversial process, in some cases requiring decades or even centuries to achieve.

<i>Morganella morganii</i> Species of bacterium

Morganella morganii is a species of Gram-negative bacteria. It has a commensal relationship within the intestinal tracts of humans, mammals, and reptiles as normal flora. Although M. morganii has a wide distribution, it is considered an uncommon cause of community-acquired infection, and it is most often encountered in postoperative and other nosocomial infections, such as urinary tract infections.

<i>Hafnia</i> (bacterium) Genus of bacteria

Hafnia is a genus of Gram-negative, facultatively anaerobic, rod-shaped bacteria in the family Hafniaceae.

Shigatoxigenic Escherichia coli (STEC) and verotoxigenic E. coli (VTEC) are strains of the bacterium Escherichia coli that produce Shiga toxin. Only a minority of the strains cause illness in humans. The ones that do are collectively known as enterohemorrhagic E. coli (EHEC) and are major causes of foodborne illness. When infecting the large intestine of humans, they often cause gastroenteritis, enterocolitis, and bloody diarrhea and sometimes cause a severe complication called hemolytic-uremic syndrome (HUS). Cattle are an important natural reservoir for EHEC because the colonised adult ruminants are asymptomatic. This is because they lack vascular expression of the target receptor for Shiga toxins. The group and its subgroups are known by various names. They are distinguished from other strains of intestinal pathogenic E. coli including enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), and diffusely adherent E. coli (DAEC).

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

<span class="mw-page-title-main">OmpT</span> Bacterial protein

OmpT is an aspartyl protease found on the outer membrane of Escherichia coli. OmpT is a subtype of the family of omptin proteases, which are found on some gram-negative species of bacteria.

Enteroaggregative Escherichia coli are a pathotype of Escherichia coli which cause acute and chronic diarrhea in both the developed and developing world. They may also cause urinary tract infections. EAEC are defined by their "stacked-brick" pattern of adhesion to the human laryngeal epithelial cell line HEp-2. The pathogenesis of EAEC involves the aggregation of and adherence of the bacteria to the intestinal mucosa, where they elaborate enterotoxins and cytotoxins that damage host cells and induce inflammation that results in diarrhea.

<i>Human coronavirus 229E</i> Species of virus

Human coronavirus 229E (HCoV-229E) is a species of coronavirus which infects humans and bats. It is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to the APN receptor. Along with Human coronavirus OC43, it is one of the viruses responsible for the common cold. HCoV-229E is a member of the genus Alphacoronavirus and subgenus Duvinacovirus.

Bacterial effectors are proteins secreted by pathogenic bacteria into the cells of their host, usually using a type 3 secretion system (TTSS/T3SS), a type 4 secretion system (TFSS/T4SS) or a Type VI secretion system (T6SS). Some bacteria inject only a few effectors into their host’s cells while others may inject dozens or even hundreds. Effector proteins may have many different activities, but usually help the pathogen to invade host tissue, suppress its immune system, or otherwise help the pathogen to survive. Effector proteins are usually critical for virulence. For instance, in the causative agent of plague, the loss of the T3SS is sufficient to render the bacteria completely avirulent, even when they are directly introduced into the bloodstream. Gram negative microbes are also suspected to deploy bacterial outer membrane vesicles to translocate effector proteins and virulence factors via a membrane vesicle trafficking secretory pathway, in order to modify their environment or attack/invade target cells, for example, at the host-pathogen interface.

The locus of enterocyte effacement-encoded regulator (Ler) is a regulatory protein that controls bacterial pathogenicity of enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic Escherichia coli (EHEC). More specifically, Ler regulates the locus of enterocyte effacement (LEE) pathogenicity island genes, which are responsible for creating intestinal attachment and effacing lesions and subsequent diarrhea: LEE1, LEE2, and LEE3. LEE1, 2, and 3 carry the information necessary for a type III secretion system. The transcript encoding the Ler protein is the open reading frame 1 on the LEE1 operon.

P fimbriae are chaperone-usher type fimbrial appendages found on the surface of many Escherichia coli bacteria. The P fimbriae is considered to be one of the most important virulence factor in uropathogenic E. coli and plays an important role in upper urinary tract infections. P fimbriae mediate adherence to host cells, a key event in the pathogenesis of urinary tract infections.

References

  1. 1 2 Albert, M J; Alam, K; Islam, M; Montanaro, J; Rahaman, A S; Haider, K; Hossain, M A; Kibriya, A K; Tzipori, S (1991). "Hafnia alvei, a probable cause of diarrhea in humans". Infection and Immunity. 59 (4): 1507–1513. doi:10.1128/iai.59.4.1507-1513.1991. ISSN   0019-9567. PMC   257869 . PMID   2004829.
  2. Albert, M. J.; Faruque, S. M.; Ansaruzzaman, M.; Islam, M. M.; Haider, K.; Alam, K.; Kabir, I.; Robins-Browne, R. (1992). "Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alvei". Journal of Medical Microbiology. 37 (5): 310–314. doi:10.1099/00222615-37-5-310. ISSN   1473-5644. PMID   1433251.
  3. Ridell, J; Siitonen, A; Paulin, L; Lindroos, O; Korkeala, H; Albert, M J (1995). "Characterization of Hafnia alvei by biochemical tests, random amplified polymorphic DNA PCR, and partial sequencing of 16S rRNA gene". Journal of Clinical Microbiology. 33 (9): 2372–2376. doi:10.1128/jcm.33.9.2372-2376.1995. ISSN   0095-1137. PMC   228415 . PMID   7494030.
  4. Janda, J. Michael; Abbott, Sharon L.; Albert, M. John (1999). "Prototypal Diarrheagenic Strains of Hafnia alvei Are Actually Members of the Genus Escherichia". Journal of Clinical Microbiology. 37 (8): 2399–2401. doi:10.1128/JCM.37.8.2399-2401.1999. ISSN   0095-1137. PMC   85237 . PMID   10405374.
  5. Huys, Geert; Cnockaert, Margo; Janda, J. Michael; Swings, Jean (2003). "Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children". International Journal of Systematic and Evolutionary Microbiology. 53 (3): 807–810. doi: 10.1099/ijs.0.02475-0 . PMID   12807204.
  6. 1 2 Bengtsson, Rebecca J.; Baker, Kate S.; Cunningham, Andrew A.; Greig, David R.; John, Shinto K.; Macgregor, Shaheed K.; Seilern-Moy, Katharina; Spiro, Simon; Chong, Charlotte C.; De Silva, P. Malaka; Jenkins, Claire; Lawson, Becki (2023-03-27). "The genomic epidemiology of Escherichia albertii infecting humans and birds in Great Britain". Nature Communications. 14 (1): 1707. Bibcode:2023NatCo..14.1707B. doi:10.1038/s41467-023-37312-3. ISSN   2041-1723. PMC   10043262 . PMID   36973246.
  7. Masuda, Kanako; Ooka, Tadasuke; Akita, Hiroko; Hiratsuka, Takahiro; Takao, Shinichi; Fukada, Mami; Inoue, Kaori; Honda, Mikiko; Toda, Junko; Sugitani, Wakana; Narimatsu, Hiroshi; Ishioka, Taisei; Hirai, Shinichiro; Sekizuka, Tsuyoshi; Kuroda, Makoto (2020-02-01). "Epidemiological Aspects of Escherichia albertii Outbreaks in Japan and Genetic Characteristics of the Causative Pathogen". Foodborne Pathogens and Disease. 17 (2): 144–150. doi:10.1089/fpd.2019.2654. ISSN   1535-3141. PMID   31603704. S2CID   204331363.
  8. Inglis, T. J. J.; Merritt, A. J.; Bzdyl, N.; Lansley, S.; Urosevic, M. N. (2015-11-01). "First bacteraemic human infection with Escherichia albertii". New Microbes and New Infections. 8: 171–173. doi:10.1016/j.nmni.2015.07.003. ISSN   2052-2975. PMC   4877401 . PMID   27257499.
  9. Ooka, Tadasuke; Seto, Kazuko; Kawano, Kimiko; Kobayashi, Hideki; Etoh, Yoshiki; Ichihara, Sachiko; Kaneko, Akiko; Isobe, Junko; Yamaguchi, Keiji; Horikawa, Kazumi; Gomes, Tânia A. T.; Linden, Annick; Bardiau, Marjorie; Mainil, Jacques G.; Beutin, Lothar (2012). "Clinical Significance of Escherichia albertii - Volume 18, Number 3—March 2012 - Emerging Infectious Diseases journal - CDC". Emerging Infectious Diseases. 18 (3): 488–492. doi:10.3201/eid1803.111401. PMC   3309589 . PMID   22377117.
  10. Yamamoto, Denise; Hernandes, Rodrigo T.; Liberatore, Ana Maria A.; Abe, Cecilia M.; Souza, Rodrigo B. de; Romão, Fabiano T.; Sperandio, Vanessa; Koh, Ivan H.; Gomes, Tânia A. T. (2017-02-08). "Escherichia albertii, a novel human enteropathogen, colonizes rat enterocytes and translocates to extra-intestinal sites". PLOS ONE. 12 (2): e0171385. Bibcode:2017PLoSO..1271385Y. doi: 10.1371/journal.pone.0171385 . ISSN   1932-6203. PMC   5298312 . PMID   28178312.
  11. Hinenoya, Atsushi; Li, Xing-Ping; Zeng, Ximin; Sahin, Orhan; Moxley, Rodney A.; Logue, Catherine M.; Gillespie, Barbara; Yamasaki, Shinji; Lin, Jun (2021). "Isolation and characterization of Escherichia albertii in poultry at the pre-harvest level". Zoonoses and Public Health. 68 (3): 213–225. doi:10.1111/zph.12812. ISSN   1863-1959. PMID   33528112. S2CID   231765097.
  12. Oaks, J. Lindsay; Besser, Thomas E.; Walk, Seth T.; Gordon, David M.; Beckmen, Kimberlee B.; Burek, Kathy A.; Haldorson, Gary J.; Bradway, Dan S.; Ouellette, Lindsey; Rurangirwa, Fred R.; Davis, Margaret A.; Dobbin, Greg; Whittam, Thomas S. (2010). "Escherichia albertii in Wild and Domestic Birds". Emerging Infectious Diseases. 16 (4): 638–646. doi:10.3201/eid1604.090695. ISSN   1080-6040. PMC   3321939 . PMID   20350378.
  13. Wang, Huiwen; Zhang, Li; Cao, Liu; Zeng, Ximin; Gillespie, Barbara; Lin, Jun (2022-04-01). "Isolation and characterization of Escherichia albertii originated from the broiler farms in Mississippi and Alabama". Veterinary Microbiology. 267: 109379. doi:10.1016/j.vetmic.2022.109379. ISSN   0378-1135. PMID   35219009. S2CID   247069093.